Skip to Main Content

Paper Details

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis.
Multiple Sclerosis and Related Disorders
4
2022
Covid, Covid-, Covid-19, EDSS, MS, Methylprednisolone, Multiple Sclerosis, anti-CD20, methylprednisolone, patient, patients
Author NameAffiliation
Paola CavallaCity of Health and Science University Hospital of Turin
Roberto BergamaschiMultiple Sclerosis Research Center, IRCCS Mondino Foundation
Giancarlo ComiInstitute of Experimental Neurology, IRCCS Ospedale San Raffaele
Marco SalvettiSapienza University of Rome, IRCCS Neuromed
  • 1 - 4

Datasets

Release 1.2